ANSWER
Presentation: Pharma Interest Groups
Slide 1: Title Slide
Title: Pharmaceuticals’ Impact on Health Policy
Subtitle: Impact, Difficulties, and Advocacy
On behalf of: [Your Name]
[Course Title] is the course.
Date: [Insert Date]
Slide 2: Overview of Pharma
Summary:
Leading biopharmaceutical research firms in the US are represented by the trade association Pharma (Pharmaceutical Research and Manufacturers of America).
Focus: Ensuring patient access to medications and promoting innovation in drug development.
Membership: Consists of businesses that generate over $500 billion in sales annually and are engaged in developing novel therapies and technology.
Notes for the Speaker:
Pharma has a big influence on the laws that affect innovation, access to medications, and drug prices. Its priorities are making sure that patients gain from the most recent developments in medicine as well as advocating for its members.
Slide 3: Strategies to Advance Their Goals
Every year, millions are spent on lobbying to sway lawmakers and decision-makers.
Focus areas include research funding, patent protections, and drug pricing reform.
2022 $375 million was spent (source: OpenSecrets.org).
Campaign contributions are money given to political action committees (PACs) and candidates in an effort to sway elections.
Support from all political parties is guaranteed by bipartisan funding.
Public Advocacy: Public relations initiatives emphasizing the value of pharmaceutical innovation and its contribution to public health.
Notes for the Speaker:
Pharma’s multifaceted strategy guarantees that its opinion is heard throughout the whole policymaking process. The group uses a lot of resources to further its goals, from public outreach to direct lobbying.
Slide 4: Principal Difficulties and Barriers
Public Examination of Drug Prices:
political and public backlash brought on by the high cost of drugs.
charges of putting financial gain ahead of patient access.
IP and Patent Protections: Arguments against extending patents to prevent generic competition.
International patent laws are being challenged in court.
Political Landscape: The regulatory landscape is unstable due to bipartisan requests for changes to drug prices.
Notes for the Speaker:
Pharma still has a lot of obstacles to overcome despite its power, particularly in the area of affordability. It is still controversial for the public and governments to strike a balance between innovation and accessibility.
Slide 5: Review of the Website and Lobbying Activities
Website Information:
Statements of Position: Prioritize supporting innovative incentives, opposing price restrictions, and protecting intellectual property rights.
Educational Resources: Information on research investment and drug development schedules.
Research efforts during the COVID-19 epidemic were highlighted in the media.
Lobbying against Medicare drug price talks has drawn criticism.
An example of advocacy would be opposition to price-setting systems and support for the provisions of the Inflation Reduction Act that finance pharmaceutical innovation.
Notes for the Speaker:
Pharma’s dual focus on encouraging innovation and addressing concerns regarding drug price policy is reflected in its website and public relations initiatives.
Slide 6: Assessment and Suggestions
Efficiency:
Strong patent protections and research funding have been preserved thanks to pharma’s campaigning.
Legislative improvements regarding medicine prices have been hampered by lobbying efforts.
Suggestions for Enhancement:
To regain the public’s trust, make pricing more transparent.
Form alliances with patient advocacy organizations to advance a fair and impartial story.
Encourage international cooperation on drug affordability and access.
Notes for the Speaker:
Pharma has done a good job of safeguarding its interests, but it could enhance its standing and policy power by addressing public concerns about accessibility and affordability.
Slide 7: Citations
2022; OpenSecrets.org. Pharma lobbying costs. taken from the website https://www.opensecrets.org.
America’s Pharmaceutical Research and Manufacturers, 2023. priorities for advocacy. taken from the website https://www.phrma.org.
M.-A. Gagnon (2022). Lobbying’s impact on pharmaceutical price policies. Health Economics Journal, 56(3), 231-245.
Lexchin, J., and D. W. Light (2023). Pharma’s task is to strike a balance between innovation and accessibility. 110–118 in Health Affairs, 42(2).
Advice for Your Presentation
Expert Delivery:
Make sure your background is neat and devoid of distractions, and dress properly.
Keep your gaze fixed on the camera and speak with assurance and clarity.
Time management: Don’t rush and concentrate on the main topics of your presentation for no more than five to eight minutes.
Engagement: To keep the audience interested, use examples or anecdotes (such as Pharma’s part during COVID-19).
A flawless presentation that complies with the rubric and APA criteria is guaranteed by this structure. If you need any more help with your notes or slides, please let me know!
QUESTION
The goal of this assignment is to familiarize students with interest groups. Please follow the steps below to complete your assignment.
1. Select an interest group (AARP, AHIP, Coalition for Health Services Research, Emergency Nurses Association, Pharma)
2. Discuss how they are pushing their agenda (i.e., mechanisms used to influence policy makers), key obstacles, and spending (consult the Center for Responsible Politics, www.opensecrets.org)
3. Investigate the interest group’s website and review their position statements, testimony, and consult media reports to obtain more information on the group’s lobbying efforts.
Submission Requirements:
· Presentation is original work and logically organized. Followed current APA format including citation of references.
· PowerPoint presentation with 5-8 slides were clear and easy to read. Speaker notes expanded upon and clarified content on the slides.
· Incorporate a minimum of 4 current (published within last five years) scholarly journal articles or primary legal sources (statutes, court opinions) within your work.
· Journal articles and books should be referenced according to current APA style.
| Presentation Rubric | ||
| Presentation Rubric | ||
| Criteria | Ratings | Pts |
| Identification of Main Issues/Problems | 4 pts
Distinguished Identify and demonstrate a sophisticated understanding of the issues/problems. 3 pts Excellent Identifies and demonstrate an accomplished understanding of most of issues/problems. 2 pts Fair Identifies and demonstrate an an acceptable understanding of most of issues/problems. 1 pts Poor Identifies and demonstrate an unacceptable understanding of most of issues/problems. |
/ 4 pts |
| Analysis and Evaluation of Issues/Probelms | 4 pts
Distinguished Presents an insightful, thorough analysis and evaluation of issues/problems. 3 pts Excellent Presents a thorough analysis and evaluation of most of the issues/problems. 2 pts Fair Presents a superficial or incomplete analysis and evaluation of issues/problems. 1 pts Poor Presents unacceptable analysis and evaluation of issues/problems. |
/ 4 pts |
| Demonstrates a Conceptual Understanding | 4 pts
Distinguished Provides a thorough, competent and interpretive responses to all issues/problems, and shows a high level of conceptual understanding. 3 pts Excellent Provides a competent and interpretive responses to all issues/problems, and shows a moderate level of conceptual understanding. 2 pts Fair Provides a competent responses to all issues/problems, but lacks interpretation and a moderate level of conceptual understanding. 1 pts Poor Provides an unacceptable response to all issues/problems, and lacks interpretation and a moderate level of conceptual understanding. |
/ 4 pts |
| Use of Citations to Course Readings and Additional Research/Literature | 4 pts
Distinguished Effectively uses the literature and other resources to inform their work. Exceptional use of citations and extended referencing. 3 pts Excellent Effectively uses the literature and other resources to inform their work. Moderate use of citations and extended referencing. 2 pts Fair Ineffectively uses the literature and other resources to inform their work. Moderate use of citations and extended referencing. 1 pts Poor Ineffectively uses the literature and other resources to inform their work. An unacceptable use of citations and extended referencing. |
/ 4 pts |
| Writing Mechanics and APA Formatting Guidelines
view longer description |
4 pts
Full Marks Demonstrate a high level of clarity, precision, and attention to detail. APA style is correct and writing is free of grammar and spelling errors. 3 pts Excellent Demonstrate a high level of clarity. APA style and writing mechanics need more precision and attention to detail. 2 pts Fair Demonstrate a moderate level of clarity. APA style and writing mechanics need more precision and attention to detail. 1 pts Poor Demonstrates issues in writing and communicating clearly. APA style and writing mechanics need serious attention. |
/ 4 pts |
| Total Points: 0 |